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1. Introduction
What is neurochemistry? As a field of study, neurochemistry is concerned 
with the types, structures and functions of the chemical components found in 
the nervous system [1]. These components in turn regulate the physiology of the 
nervous system [2–4]. Neurochemistry is mainly concerned with the chemicals 
that are specifically found in the nervous system such as small organic molecules, 
neurotransmitters and neuropeptides. Neurological diseases are often a reflection 
of changes in the body’s neurochemistry, e.g., in Alzheimer’s disease or Parkinson’s 
disease. Medicine uses neurochemicals to alter brain function and treat disease. 
Neurochemists study how the components of the nervous system are at work during 
processes such as neural plasticity, neural development, learning and memory 
formation and how these components undergo changes during disease processes, 
neural dysfunction, and aging. This chapter will introduce the chemical compo-
nents of the nervous system and briefly discuss how external and internal factors 
impact and modify these components.
2. Building blocks of the nervous system
The nervous system comprises a vast array of cells that vary in form and func-
tion and how they interact with other cells. The two principal types of cells are 
nerve cells or neurons and glial cells. Both types have many subtypes that are 
named based either on their shape or function. Neurons can be broadly classified 
as unipolar, bipolar, multipolar or pseudounipolar based on their arrangement and 
presence of dendrites and axons, or they are classified as sensory, motor or inter-
neurons based on their function in neural networks. Dendrites are considered as 
the recipient portion of a nerve cell while axons carry information to other parts 
of the nervous system. However, this distinction can be blurred in neural circuits 
where both axons and dendrites can serve in either function. Axons reach a length 
of 1.5 m in adult humans and are even longer in larger animals such as giraffes. 
While axons serve as long-distance communication devices for information through 
the propagation of action potentials, axons also transport physical material toward 
the axonal terminal and from the terminal to the cell body. Protein synthesis takes 
place in the cell body where genetic information is located. Therefore, all proteins 
and also organelles such as mitochondria that are needed in the axon terminal have 
to be shipped down the axon with the help of motor proteins. Two motor proteins, 
kinesin and dynein, move vesicles or organelles along microtubules in the axon. 
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Kinesin moves vesicles toward the terminal or away from the center of the neuron 
(anterograde axonal transport) while dynein moves in the opposite direction, 
namely from the terminal toward the cell body (retrograde axonal transport).
Glial cells also come in different flavors. Glial cells are increasingly recognized 
for their physiological functions in the nervous system and have been named 
“the unsung heroes of the brain” [5]. Certain glial cell types are found only in the 
peripheral nervous system such as satellite cells or myelin-forming Schwann cells, 
while others are housed in the central nervous system (brain and spinal cord) such 
as astrocytes (fibrous and protoplasmic), microglia and myelin-forming oligoden-
drocytes. Despite these commonly accepted classifications, it should be clear that 
nerve cells are so varied in their morphology that it has been virtually impossible to 
adequately classify them based on shape, ultrastructure, neurotransmitter profile, 
physiology or location. Furthermore, neurons with similar form and function 
have been described in distant animal taxa that do not share recent phylogenetic 
relations.
Nerve cells are equipped with cellular machinery that is present in most other 
cell types such as nucleus, Golgi apparatus, mitochondria, smooth and rough endo-
plasmic reticulum. Histological staining of nerve cells with dyes such as toluidine 
blue or cresyl violet (Nissl staining, nucleic acid stain) reveals particularly intense 
labeling of the nucleolus and Nissl substance in the cytoplasm [6]. Nissl substance 
refers to free ribosomes in the cytoplasm and bound ribosomes on the ER. This 
heavy staining pattern is a reflection of the active metabolism and continuous 
production of peptides and proteins in nerve cells and identifies nerve cells among 
the most active cells in the body.
3. Excitable cell membranes and channelopathies
Nerve cells and glial cells are compartmentalized by membranes that are built by 
lipids and proteins. These lipids and proteins are key elements for the unique func-
tional role each neuron plays in the neural circuit and for the intracellular activities 
that occur in axons and dendrites distant from the cell nucleus. During develop-
ment, axonal guidance and remodeling of dendritic spines are shaped in response 
to signal input at local membrane compartments which is communicated to the 
cell interior through specific receptors and channels. The inside and outside of the 
cellular membranes are different from each other, such that an asymmetric distribu-
tion of lipids and proteins between cytoplasmic and exoplasmic leaflets allows for 
an unequal division of labor [1]. Lipids are critically relevant for the structure and 
function of the nervous system. Membrane lipids are the main component of the 
myelin that ensheathes axons both in the central and peripheral nervous system. 
Furthermore, at the connections between nerve cells, the synapses, membranes 
have unique lipid compositions. The synapse is equipped with a synaptic machin-
ery of vesicles and proteins that contribute to the specialized properties of these 
membrane compartments and to the plastic changes in synaptic transmission from 
pre- to postsynaptic neurons (synaptic plasticity) [7–9]. Lipid intermediates and 
lipid modification play roles in signaling pathways related to cell differentiation and 
in modulating the activity of trophic factors and receptors [1].
Nerve cells are excitable cells with unique properties in transferring informa-
tion. In order to do so, the membranes of nerve cells are equipped with highly 
selective pores or ion channels for sodium, potassium, calcium and chloride ions. 
These channels are critical for membrane excitation and propagation of action 
potentials. Ion channels are responsive to changes in voltage (voltage gated chan-
nels), binding of a chemical (ligand gated channels) or mechanical perturbation. 
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Channelopathies, disorders of ion channels, are resulting from disturbed ion 
channel function due to problems with ion channel subunits or regulation of the 
ion channels [10]. The rapidly growing field of channelopathies started with the 
discovery of voltage gated channelopathies that result in inherited muscle disease 
due to mutations in a subunit of the sodium channel or a mutation in a gene cod-
ing for a chloride channel in skeletal muscle [10]. Channelopathies have also been 
identified for ligand gated ion channels due to mutations of a subunit of the glycine 
receptor or a subunit of the nicotinic acetylcholine receptor [11, 12]. The underlying 
reasons for channelopathies can be traced back to either inherited causes (congeni-
tal, resulting from one or more mutations in the genes encoding the ion channel) or 
acquired causes such as toxins and autoimmune attack on an ion channel.
4. Neurotransmitters and neuropeptides
The best known neurochemicals are neurotransmitters and neuropeptides since 
they modulate brain function [1–4]. One set of neurotransmitters is formed by 
common amino acids such as glutamate, gamma-aminobutyric acid (GABA) and 
glycine. These amino acids have a number of functions throughout the body. In nerve 
terminals of neurons, they are packaged and stored in secretory or synaptic vesicles, 
so they can be released by exocytosis in a calcium dependent manner. The vesicular 
membrane is recycled, i.e., endocytosed, for future synaptic release cycles. Glutamate 
is the most prominent excitatory neurotransmitter. It is released at excitatory syn-
apses, and evokes membrane potential depolarization and, possibly, firing of action 
potentials in the connected postsynaptic cell. In contrast, GABA is the best known 
inhibitory neurotransmitter. Its action results in reducing neuronal excitability. 
Glycine is another inhibitory neurotransmitter found in the spinal cord, brainstem 
and retina. The monoamines form an important group of neurotransmitters involved 
in regulation of emotion, arousal, some forms of memory as well as sensory process-
ing [1–4, 13, 14]. Because of their functional roles, drugs are used to regulate their 
effects in patients with psychiatric as well as neurological disorders [15]. As their 
name implies, monoamines contain an amino group connected to an aromatic ring 
by a two-carbon chain. The enzymes monoamine oxidases terminate the action of 
monoamines. Histamine, serotonin, dopamine, epinephrine (adrenaline), norepi-
nephrine (noradrenaline) are monoamines. The latter three are also grouped together 
as catecholamines because they contain a catechol group. Trace amines such as 
octopamine, tryptamine, tyramine, phenethylamine and others, have been identified 
as neurotransmitters. Neuropeptides include compounds such as oxytocin, substance 
P, somatostatin, opioid peptides, cocaine and amphetamine regulated transcript 
(CART), glucagon, orexin, dynorphin, endorphin, enkephalin, neuropeptide Y, 
neuropeptide S, and others. Nitric oxide, hydrogen sulfide and carbon monoxide 
act as gaseous neurotransmitters [16]. These neurotransmitters are synthesized de 
novo in nerve cells and because of their chemical nature are able to rapidly diffuse 
through the plasma membrane to act on neighboring cells. Acetylcholine is released 
in the autonomic nervous system and also from motor neurons at the neuromuscular 
junction to evoke skeletal muscle contraction. Chemically, acetylcholine is an ester of 
acetic acid and choline. Endogenously produced cannabinoids (endocannabinoids) 
such as anandamide differ from the above mentioned neurotransmitters because 
they are formed from membrane lipids and are essentially lipids. They can be rapidly 
synthesized on demand from the cell membrane and released nonsynaptically and 
not from synaptic vesicles as the classic neurotransmitters, reviewed in [9, 17, 18]. 
Endocannabinoids bind to cannabinoid receptors on presynaptic neurons to regulate 
presynaptic neurotransmitter release. Therefore, endocannabinoids together with the 
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gaseous neurotransmitters are unusual neurotransmitters [17, 19, 20]. One key dis-
tinction of these novel neurotransmitters is the fact that they act as retrograde mes-
sengers at synapses and presynaptically regulate either glutamatergic or GABAergic 
synapses to alter release-probability in synaptic plasticity. Gaseous neurotransmitters 
and endocannabinoids have been shown to have a functional role in experience-
dependent activity and mediate a variety of forms of short- and long-term synaptic 
plasticity [21–24].
5. Factors that influence neurochemistry
What are some of the factors that affect the chemistry of the nervous system? 
Factors that modify neurochemistry include sensory stimuli, environmental signals 
such as recreational drugs, pharmaceuticals and toxins, and bodily changes such as 
aging and disease. Listed below, and described in more detail, are examples of some 
such factors known to influence neurochemistry. It is important to realize that this 
list is not exhaustive, and that in theory almost any external stimulus or internal 
state could influence neurochemistry.
5.1 Sleep
Sleep is controlled by circadian rhythms, which have a neurochemical (and 
oscillatory epigenetic) basis. During waking, several brain structures participate, 
namely the basal forebrain, posterior and lateral hypothalamus, and nuclei in the 
tegmentum and pons. Neurotransmitters that act as significant wakefulness factors 
are acetylcholine and monoamines, glutamate and hypocretin/orexin. Conversely, 
the preoptic/anterior hypothalamic area regulates active sleep mechanisms, and 
sleep is promoted by GABA and peptide factors, including growth hormone-releas-
ing hormone, cytokines, and prolactin [25]. Adenosine is a significant homeostatic 
factor acting in basal forebrain and preoptic areas via A1 and A2A receptors. Lack of 
sleep increases inducible nitric oxide synthase in the basal forebrain, which causes 
adenosine release and recovery sleep. Also, many genes have been found differen-
tially expressed in wakefulness versus sleep, and they relate to neural transmission, 
energy metabolism, stress protection, and synaptic plasticity [25].
5.2 Exercise
There has recently been a large amount of research into the neurochemical 
changes that occur during and after exercise, finding that it stimulates the increase 
of many chemicals, namely lactate, cortisol, neurotrophins, including BDNF, VEGF 
and IGF-1, neurotransmitters, including dopamine, serotonin, norepinephrine, 
GABA, acetylcholine, and glutamate, and neuromodulators, including endocan-
nabinoids and endogenous opioids [26]. However, it should be noted that many 
of these alterations have been demonstrated only peripherally, and gaps still exist 
in our knowledge as to exactly where these changes occur in the brain. Therefore, 
further work is needed to link the exercise-induced changes in peripheral levels to 
central levels, and to understand how these chemicals are involved in the exercise-
induced changes in cognition, mood, and so forth [26].
5.3 Diet
The scientific field concerned with the effects various contents of the diet 
such as macronutrients, and micronutrients such as minerals, vitamins, dietary 
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supplements, and food additives have on neurochemistry is called “nutritional 
neuroscience.” Recent research on nutrition and its effect on the brain show that 
it is involved in almost every aspect of neurological function, modulating neuro-
trophic factors, neural pathways, neurogenesis, and neuroplasticity [27]. This is 
not surprising when we consider that the brain consumes a very large amount of 
energy relative to the rest of the body. Specifically, the human brain is approxi-
mately 2% of the body mass but uses up to 25% of the energy input. Therefore, 
mechanisms involved in the transfer of energy from foods to neurons are likely 
to be essential to the control of brain function. Furthermore, insufficient intake 
of certain vitamins and other cofactors, or the consequences of metabolic disor-
ders such as diabetes, affect cognition by altering processes in the body that are 
associated with the management of energy and synthesis of neurotrophic and 
neuroendocrine factors (i.e., BDNF and IGF-1) as well as neurotransmitter in 
neurons, which can subsequently affect neurotransmission, synaptic plasticity, 
and cell survival [27].
5.4 Stress
Stress has been defined as a brain-body reaction to stimuli from the envi-
ronment or from internal states that are interpreted by the body as disrupted 
homeostasis [28]. The response to such stress involves both the activity of dif-
ferent neurotransmitters in the limbic system, and the response of neurons 
there to other chemicals and hormones, mainly glucocorticoids, released from 
the adrenal cortex. Thus, body-brain integration probably plays a major role in 
the stress response [28]. Specifically, acute stress is correlated with alterations 
of neurotransmitters such as dopamine, acetylcholine, GABA and glutamate in 
areas of the brain associated with the regulation of stress responses. These areas 
include the prefrontal cortex, amygdala, nucleus accumbens, and hippocampus. 
Glucocorticoids also play an important role, and interact with several neurotrans-
mitters in those same areas of the brain. Also, the actions of neuromodulators 
released from peripheral organs such as the liver (IGF-1), pancreas (insulin), or 
gonads (estrogens) play a role [28]. A permanent increase in the baseline levels 
of glucocorticoids arising from a stressful lifestyle could exacerbate neuronal 
damage that occurs in the above areas of the brain during aging. Conversely, stress 
reduction may have an anti-aging effect [29].
5.5 Meditation
One way to counteract stress is through practices such as meditation and yoga. 
These techniques have recently received increased attention due to the accumula-
tion of research showing both direct and indirect benefits [30]. Based on studies 
conducted so far, it has been found that the practice of meditation influences the 
levels of neurotransmitters such as GABA, serotonin, dopamine, and norepineph-
rine, in a way that positively affects psychological disorders such as anxiety. Also, by 
reducing baseline levels of stress hormones and neurotransmitters, meditation may 
act as a form of preventative medicine [30].
5.6 Alcohol
Alcohol has effects on many neurotransmitters in the brain. Its major effect is 
to stimulate the release of GABA, and it acts principally at the GABAA receptors, 
and thereby has sedative effects [31]. It also inhibits postsynaptic NMDA excit-
atory glutamate receptors, and this inhibition further contributes to the sedation. 
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However, alcohol also has euphoric effects, and these are more related to increases 
in dopamine. The effects on dopamine are also thought to be involved in alcohol 
craving and relapse. In addition, alcohol alters opioid receptors and can lead to a 
release of β-endorphins. Additional important effects include increased serotonin 
and decreased nicotinic acetylcholine receptors [31].
5.7 Recreational drugs
Drugs can alter the regular functions of neurochemicals, inhibit the way 
they are supposed to act, or disrupt their communication [32]. At first, plea-
sure is usually increased, but cognitive ability and rationality are decreased. 
Psychomotor stimulant drugs like amphetamines, methamphetamine, and 
cocaine cause an overproduction of neurotransmitters, principally the mono-
amines dopamine and norepinephrine, and may also prevent them from being 
reabsorbed, causing an abnormally large amount to be present in synapses, and 
thereby activate the mesolimbic dopamine system. Drugs like ecstasy (3,4-meth-
alynedioxymethamphetamine) similarly interfere with the transmission of 
serotonin, and the way it is transported along neural pathways. Other drugs, 
such as heroin, opioids, and marijuana, mimic endogenous brain chemicals and 
bind to receptors as agonists, activating the neurons and thus disrupting the 
natural transmission and production of neurotransmitters [32]. With repeated 
drug abuse, the brain can be rewired via neuroplasticity as it attempts to main-
tain chemical homeostasis [33].
5.8 Neurodegenerative diseases and aging
Studies of the neurobiology of aging are beginning to uncover the mechanisms 
underlying not only the physiology of aging of the brain, but also the mechanisms 
that make people more vulnerable to cognitive dysfunction and neurodegenera-
tive diseases [29]. Neurotransmission is impaired in age-related disorders, such 
as Alzheimer’s and Parkinson’s diseases, which has stimulated investigations into 
the neurochemistry of the aging human brain. Out of all the neurotransmit-
ter systems studied, age-related changes in the serotonergic, cholinergic, and 
dopaminergic systems are the most reliably found [34]. The dopamine system 
in particular, is especially vulnerable to aging [35]. The association of these 
neurotransmitters with mood, memory, and motor function may contribute to 
age-associated behavioral changes and predispose older people to age-related 
diseases. Moreover, age-related neurodegenerative diseases may evolve from the 
interaction between defects in specific neurochemical mechanisms and other 
pathophysiologic processes [33].
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